Conclusion: The symptoms and unique findings that make up RS(3)PE appear to represent a steroid-responsive disease that may be a harbinger of an underlying malignancy. More study is needed to understand the molecular origins of RS(3)PE in order to determine whether it is a separate disease process. Patients with concurrent cancer tend to have more severe presentations and higher rates of recurrence.
PubMed 27050250 ↗Prednisone
The short answer. There isn't much data on Prednisone yet — 15 mentions, 13 with a clear outcome — so treat these numbers as anecdotal. It is most often used for pain & inflammation: 100% of 5 reports say that improved. It is well studied — 608 meta-analyses on PubMed.
From 15 mentions in total — the rest didn't say how it went and aren't counted.
What Prednisone does, according to users
Of the people who reported each effect, the share who said it got better.
4 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 608 meta-analyses on PubMed ↗ · 3,012 randomized trials ↗
Conclusion: In severe pneumonia and ARDS, adjunct corticosteroids probably reduce short-term mortality. In severe pneumonia, they may reduce secondary shock. In both conditions, corticosteroids may have little or no effect on hospital-acquired infections.
PubMed 41325621 ↗Conclusion: The heterogeneity of glucocorticoid use is reflected in the available studies. Despite this heterogeneity, the proportion of neuropsychiatric adverse effects in glucocorticoid users is high. The most substantial associations with glucocorticoid use were found for depression and mania. Upon starting glucocorticoid treatment, awareness of possible psychiatric side effects is essential. More structured studies on incidence and potential pathways of neuropsychiatric side effects of prescribed glucocorticoids are clearly needed.
PubMed 38038629 ↗Conclusion: Systemic corticosteroids for acute urticaria or chronic urticaria exacerbations likely improve urticaria, depending on antihistamine responsiveness, but also likely increase adverse effects in approximately 15% more.
PubMed 38642709 ↗2,502 human trials on ClinicalTrials.gov test Prednisone — 1,147 completed, 310 recruiting now. See all on ClinicalTrials.gov ↗
- Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia · Congenital Adrenal Hyperplasia · 2018
- A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHER) · Lymphoma, B-Cell · 2016
- Tocilizumab in Cardiac Transplantation · Heart Transplant · 2025
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
The current US prescription label has no boxed warning.
The FDA found Prednisone as an undeclared ingredient in 1 product sold as supplements, most recently on 2023-05-08. FDA tainted-products database ↗
12 recalls of products named for Prednisone. Most recent:
- 2024-01-03 · Class II: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. record ↗
- 2022-08-17 · Class II: Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets record ↗
- 2020-08-26 · Class II: Labeling: Label Mix Up: bottle labeled to contain Prednisone Tablets, USP 2.5 mg actually contained Prednisone Tablets, USP 10 mg record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
499,934 adverse-event reports mention Prednisone. Most often reported:
- Drug ineffective · 66,430
- Off label use · 55,471
- Fatigue · 40,818
- Pain · 37,879
- Dyspnoea · 34,949
- Arthralgia · 33,217
Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗
NIH has funded 47 research projects with Prednisone in the title, $19,043,748 in total (1985–2020). NIH RePORTER ↗
Plain-language guides from the US government: MedlinePlus: Prednisone ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“It was probably the best I have ever felt because I actually had energy for once.”
“When I was really sick I was on prednisone and opioids and my T levels got to 190ng/dL.”
“I had all-day get up and go energy, only needed 6.5 hours of sleep, and also slept reasonably well.”
“I have a prescription for prednisone, so I took 40 mg. I was beaming with energy all day”
Prednisone compared
Other options for pain & inflammation
Sources
- User reports: 15 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA drug label (DailyMed) ↗
- FDA adverse-event reports (FAERS) ↗
- FDA recalls ↗
- FDA tainted-products database ↗
- MedlinePlus (NIH) ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate